|
Sign In to gain access to subscriptions and/or personal tools.
|
Delivery of Doxorubicin from Biodegradable PEG Hydrogels Having Schiff Base Linkages
Hiroshi Saito
Center for Bioengineering, University of Washington, Seattle WA 98195, USA
Allan S. Hoffman
Center for Bioengineering, University of Washington, Seattle WA 98195, USA, hoffman{at}u.washington.edu
Hiroaki Iyehara Ogawa
Graduate School of Life Science and System Engineering Kyushu Institute of Technology, Kitakyushu Fukuoka 808-0196, Japan
In our quest to develop new drug delivery systems, we designed and synthesized PEG-conjugates and PEG-hydrogels with a degradable linkage to the drug. Specifically, methoxyPEG-doxorubicin (MPEG-CH=N-Doxo) and doxorubicin-PEG aldehyde (OHC-PEG-CH=N-Doxo) conjugates, plus poly (vinyl amine)-PEG-doxorubicin (PVAm-PEG-Doxo) hydrogels were prepared. The hydrogels were crosslinked by PEG-Schiff base linkages, and the Doxo was conjugated to the gel by pendant Schiff base bonds (PVAm-N=CH-PEG-CH=N-Doxo). The release profile of Doxo from the hydrogels was dependent on pH and on the ratio of PVAm to the PEG-dialdehyde crosslinker. These degradable PEG hydrogels could be good candidates for slow release of Doxo from subcutaneous or IM implants.
Key Words: drug delivery hydrogel biodegradable PEG schiff base doxorubicin.
References
- Merrill, E.W. and Salzman, E.W. (1983). Polyethylene Oxide as a Biomaterial, ASAIO J, 6: 60—64.
- Harris, J.M. and Zalipsky, S. (eds). (1997). Poly(ethylene glycol) Chemistry and Biological Applications, ACS Symposium Series 680, ACS, Washington, DC.
- Harris, J.M., Martin, N.E. and Modi, M. (2001). PEGylation: A Novel Process for Modifying Pharmacokinetics, Clin Pharmacokinet., 40: 539—551.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hinds, K.D. and Kim, S.W. (2002). Effects of PEG Conjugation on Insulin Properties, Adv Drug Deliv Rev, 54: 505—530.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Maeda, H. (2001). The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: the Key Role of Tumor-selective Macromolecular Drug Targeting, Adv Enzyme Regul, 41: 189—207.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bailon, P. and Berthold, W. (1998). Polyethylene Glycol-conjugated Pharmaceutical Proteins, Pharm Sci Technol Today, 1: 352—356.[CrossRef]
- Harris, J.M. and Chess, R.B. (2003). Effect of PEGylation on Pharmaceuticals, Nat Rev Drug Discov, 2: 214—221.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Duncan, R. (2006). Polymer Conjugates as Anticancer Nanomedicines, Nat Rev Cancer, 6: 688—701.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zalipsky, S. (1995). Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates, Bioconjug Chem, 6: 150—165.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zalipsky, S. (1995). Chemistry of Polyethylene Glycol Conjugates with Biologically Active Molecules, Adv Drug Deliv Rev, 16: 157—182.[CrossRef][Web of Science]
- Veronese, F.M. (2001). Peptide and Protein PEGylation: a Review of Problems and Solutions, Biomaterials, 22: 405—417.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Roberts, M.J., Bentley, M.D. and Harris, J.M. (2002). Chemistry for Peptide and Protein PEGylation, Adv Drug Deliv Rev, 54: 459—476.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Roberts, M.J. and Harris, J.M. (1998). Attachment of Degradable Poly(ethylene glycol) to Proteins Has the Potential to Increase Therapeutic Efficacy, J Pharm Sci, 87: 1440—1445.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kratz, F., Beyer, U. and Schutte, M.T. (1999). Drug-polymer Conjugates Containing Acid-cleavable Bonds, Crit Rev Ther Drug Carrier Syst, 16: 245—288.[Web of Science][Medline]
[Order article via Infotrieve]
- Murthy, N., Campbell, J., Fausto, N., Hoffman, A.S. and Stayton, P.S. (2003). Design and Synthesis of pH-responsive Polymeric Carriers that Target Uptake and Enhance the Intracellular Delivery of Oligonucleotides, J Contr Rel, 89: 365—374.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Murthy, N., Campbell, J., Fausto, N., Hoffman, A.S. and Stayton, P.S. (2003). Bioinspired pH-responsive Polymers for the Intracellular Delivery of Biomolecular Drugs, Bioconjug Chem, 14: 412—419.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Etrych, T., Jelinkova, M., Rihova, B. and Ulbrich, K. (2001). New HPMA Copolymers Containing Doxorubicin Bound via pH-sensitive Linkage: Synthesis and Preliminary In Vitro and In Vivo Biological Properties, J Contr Rel, 73: 89—102.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ulbrich, K. and Subr, V. (2004). Polymeric Anticancer Drugs with pH-controlled Activation, Adv Drug Deliv Rev, 56: 1023—1050.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yoo, H.S., Lee, E.A., and Park, T.G. (2002). Doxorubicin-conjugated Biodegradable Polymeric Micelles Having Acid-cleavable Linkages, J Contr Rel, 82: 17—27.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Duncan, R., Kopeckova-Rejmanova, P., Strohalm, J., Hume, I., Cable, H.C., Pohl, J., Lloyd, J.B. and Kopecek, J. (1987). Anticancer Agents Coupled to N-(2-Hydroxypropyl) Methacrylamide Copolymers. 1. Evaluation of Daunomycin and Puromycin Conjugates In Vitro, Brit J Cancer, 55: 165—174.
- Duncan, R., Hume, I., Kopeckova, P., Ulbrich, K., Strohalm, J. and Kopecek, J. (1989). Anticancer Agents Coupled to N-(2-Hydroxypropyl) Methacrylamide Copolymers. 3. Evaluation of Adriamycin Conjugates Against Mouse Leukemia L1210 In Vivo, J Contr Rel, 10: 51—63.[Medline]
[Order article via Infotrieve]
- Cuchelkar, V. and Kopecek, J. (2006). Polymer-Drug Conjugates, In: Uchegbu, I.F. and Schatzlein, A.G. (Eds), Polymers in Drug Delivery, pp. 155—182, CRC Press, Boca Raton, FL.
- Bulmus, E.V., Woodward, M., Lin, L., Murthy, N., Stayton, P.S. and Hoffman, A.S. (2003). A New pH-responsive and Glutathione-reactive, Endosomal Membrane-disruptive Polymeric Carrier for Intracellular Delivery of Biomolecular Drugs, J Contr Rel, 93: 105—120.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ohya, Y., Kuroda, H., Hirai, K. and Ouchi, T. (1995). Synthesis and Cytotoxic Activity of Conjugates of Monomethoxy-poly-(ethylene glycol) End-capped with Doxorubicin via Ester, Amide, or Schiff's Base Bond, J Bioactive and Compat Polym, 10: 51—66.
- Murakami, Y., Yokoyama, M., Okano, T., Nishida, H., Tomizawa, Y., Endo, M. and Kurosawa, H. (2007). A Novel Synthetic Tissue-adhesive Hydrogel Using a Crosslinkable Polymeric Micelle, J Biomed Mater Res A, 80: 421—427.
Journal of Bioactive and Compatible Polymers, Vol. 22, No. 6,
589-601 (2007)
DOI: 10.1177/0883911507084653

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S.-M. Lee, B.-G. Kim, C.-S. Ha, I. Chung, and Dong Xie
Syntheses and Evaluations of Antitumor and Antiangiogenic Compounds Conjugated with 5-Fluorouracil and Ascorbic Acid
Journal of Bioactive and Compatible Polymers,
September 1, 2008;
23(5):
473 - 489.
[Abstract]
[PDF]
|
 |
|
|
|